Rhelion Life Sciences Overview

  • Year Founded
  • 1982

Year Founded

  • Status
  • Public

  • Stock Symbol
  • RHEL

Stock Symbol

  • Investments
  • 18

  • Share Price
  • $0.02
  • (As of Friday Closing)

Rhelion Life Sciences General Information

Description

Rhelion Life Sciences Corp is a pharmaceutical research and development company focused on the discovery and development of natural psychedelic medicines for psychiatric and neurological conditions. Its products include Botanical Psilocybin, Botanical Coca Extract, and Botanical Ibogaine. The Company operates in the Netherlands, Canada, and the United States, with maximum revenue from the Netherlands.

Contact Information

Website
www.redlight.co
Formerly Known As
Added Capital, Red Light Holland
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1 Adelaide Street East
  • Suite 801
  • Toronto, Ontario M5C 2V9
  • Canada
+1 (647)
Primary Industry
Food Products
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
CNQ
Vertical(s)
Corporate Office
  • 1 Adelaide Street East
  • Suite 801
  • Toronto, Ontario M5C 2V9
  • Canada
+1 (647)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rhelion Life Sciences Stock Performance

As of 13-Nov-2026, Rhelion Life Sciences’s stock price is $0.02. Its current market cap is $10.8M with 614M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.02 $0.01 - $0.04 $10.8M 614M 223K

Rhelion Life Sciences Financials Summary

As of 30-Jun-2026, Rhelion Life Sciences has a trailing 12-month revenue of $2.23M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 6,702 1,648 1,100 7,439
Revenue 2,228 3,035 3,548 3,522
EBITDA (5,352) (5,075) (2,757) (5,272)
Net Income (5,021) (4,415) (2,901) (5,652)
Total Assets 15,383 10,459 14,829 17,824
Total Debt 1,017 1,019 1,526 1,270
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rhelion Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rhelion Life Sciences‘s full profile, request access.

Request a free trial

Rhelion Life Sciences Patents

Rhelion Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022232933-A1 Personalized microdosing kits and protocols based on biometric and movement data correlated with natural product qualities Inactive 04-May-2021
US-11806162-B2 Methods and systems for the use of 3d human movement data Active 28-Jul-2020
US-20230172536-A1 Methods and systems for the use of 3d human movement data Active 28-Jul-2020 A61B5/4848

Rhelion Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Rhelion Life Sciences‘s full profile, request access.

Request a free trial

Rhelion Life Sciences Investments & Acquisitions (18)

Rhelion Life Sciences’s most recent deal was a Merger/Acquisition with Filament Health for . The deal was made on 29-Apr-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Filament Health 29-Apr-2026 Merger/Acquisition Drug Discovery
Happy Caps Mushroom Farm 02-Apr-2024 Secondary Transaction - Private Horticulture
SmartShop Utrecht 26-Jul-2022 Merger/Acquisition Specialty Retail
Red Light Holland (100 Acres of Farmland in Peterborough, Ontario) 20-Jun-2022 Corporate Asset Purchase Buildings and Property
MiniChamp 10-Apr-2022 Merger/Acquisition Food Products
You’re viewing 5 of 18 investments and acquisitions. Get the full list »

Rhelion Life Sciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Food Products

Industry

Rank

Percentile

Packaged Foods

Subindustry

Rank

Percentile

To view Rhelion Life Sciences’s complete esg history, request access »

Rhelion Life Sciences Exits (4)

Rhelion Life Sciences’s most recent exit was on 26-Jul-2022 from SmartShop Utrecht. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
SmartShop Utrecht 26-Jul-2022 Completed
Mera Life Sciences 24-Aug-2021 Completed
Patricia Mining 15-Sep-2005 Completed
African Aura Resources PIPE Completed
To view Rhelion Life Sciences’s complete exits history, request access »

Rhelion Life Sciences Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Filament Health Vancouver, Canada 2020
MiniChamp Horst, Netherlands 2006

Rhelion Life Sciences FAQs

  • When was Rhelion Life Sciences founded?

    Rhelion Life Sciences was founded in 1982.

  • Where is Rhelion Life Sciences headquartered?

    Rhelion Life Sciences is headquartered in Toronto, Canada.

  • What industry is Rhelion Life Sciences in?

    Rhelion Life Sciences’s primary industry is Food Products.

  • Is Rhelion Life Sciences a private or public company?

    Rhelion Life Sciences is a Public company.

  • What is Rhelion Life Sciences’s stock symbol?

    The ticker symbol for Rhelion Life Sciences is RHEL.

  • What is the current stock price of Rhelion Life Sciences?

    As of 13-Nov-2026 the stock price of Rhelion Life Sciences is $0.02.

  • What is the current market cap of Rhelion Life Sciences?

    The current market capitalization of Rhelion Life Sciences is $10.8M.

  • What is Rhelion Life Sciences’s current revenue?

    The trailing twelve month revenue for Rhelion Life Sciences is $2.23M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process